Clinical Trial Update: Safety of DAbigatran and RIvaroxaban Versus NAdroparin in the Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial comparing dabigatran and rivaroxaban with nadroparin for venous thromboembolism prevention after knee arthroplasty has completed and reported safe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Fraxiparine (nadroparin calcium)
• Pradaxa (dabigatran etexilate)
• Xarelto (rivaroxaban)

Snippet

Sponsor: Martini Hospital Groningen | Conditions: Venous Thromboembolism | Phase 3 | Status: COMPLETED